Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-07-08

Clinical Trial Update: STereotactic Body Radiotherapy (SBRT) for Oligoprogressive Breast Cancer [NA]

View source ↗

Summary

A clinical trial is exploring stereotactic body radiotherapy for oligoprogressive metastatic breast cancer, sponsored by Juravinski Cancer Center, with recruitm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Juravinski Cancer Center | Conditions: Metastatic Breast Cancer, Oligoprogression | NA | Status: NOT_YET_RECRUITING